annual CFO:
-$205.79M+$295.21M(+58.92%)Summary
- As of today (June 22, 2025), SRPT annual cash flow from operations is -$205.79 million, with the most recent change of +$295.21 million (+58.92%) on December 31, 2024.
- During the last 3 years, SRPT annual CFO has risen by +$237.38 million (+53.56%).
- SRPT annual CFO is now -291.49% below its all-time high of $107.47 million, reached on December 31, 2020.
Performance
SRPT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$583.44M-$675.48M(-733.85%)Summary
- As of today (June 22, 2025), SRPT quarterly cash flow from operations is -$583.44 million, with the most recent change of -$675.48 million (-733.85%) on March 1, 2025.
- Over the past year, SRPT quarterly CFO has dropped by -$341.36 million (-141.01%).
- SRPT quarterly CFO is now -192.94% below its all-time high of $627.79 million, reached on March 31, 2020.
Performance
SRPT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$547.15M-$341.36M(-165.88%)Summary
- As of today (June 22, 2025), SRPT TTM cash flow from operations is -$547.15 million, with the most recent change of -$341.36 million (-165.88%) on March 1, 2025.
- Over the past year, SRPT TTM CFO has dropped by -$13.47 million (-2.52%).
- SRPT TTM CFO is now -272.30% below its all-time high of $317.56 million, reached on March 31, 2020.
Performance
SRPT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SRPT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +58.9% | -141.0% | -2.5% |
| 3 y3 years | +53.6% | -476.7% | -50.3% |
| 5 y5 years | +54.9% | -192.9% | -272.3% |
SRPT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.9% | -733.9% | at low | -165.9% | at low |
| 5 y | 5-year | -291.5% | +58.9% | -192.9% | at low | -272.3% | +22.1% |
| alltime | all time | -291.5% | +58.9% | -192.9% | at low | -272.3% | +22.1% |
SRPT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$583.44M(-733.9%) | -$547.15M(+165.9%) |
| Dec 2024 | -$205.79M(-58.9%) | $92.05M(-230.2%) | -$205.79M(-41.6%) |
| Sep 2024 | - | -$70.70M(-573.2%) | -$352.49M(-11.1%) |
| Jun 2024 | - | $14.94M(-106.2%) | -$396.50M(-25.7%) |
| Mar 2024 | - | -$242.08M(+342.9%) | -$533.67M(+6.5%) |
| Dec 2023 | -$500.99M(+54.0%) | -$54.66M(-52.4%) | -$500.99M(-7.0%) |
| Sep 2023 | - | -$114.71M(-6.2%) | -$538.73M(+10.2%) |
| Jun 2023 | - | -$122.23M(-41.6%) | -$488.99M(+12.8%) |
| Mar 2023 | - | -$209.40M(+126.6%) | -$433.57M(+33.3%) |
| Dec 2022 | -$325.35M(-26.6%) | -$92.39M(+42.2%) | -$325.35M(+24.0%) |
| Sep 2022 | - | -$64.96M(-2.8%) | -$262.28M(-18.5%) |
| Jun 2022 | - | -$66.81M(-34.0%) | -$321.64M(-11.6%) |
| Mar 2022 | - | -$101.17M(+245.0%) | -$363.98M(-17.9%) |
| Dec 2021 | -$443.17M(-512.4%) | -$29.33M(-76.4%) | -$443.17M(-24.7%) |
| Sep 2021 | - | -$124.33M(+13.9%) | -$588.38M(-16.2%) |
| Jun 2021 | - | -$109.15M(-39.5%) | -$702.24M(+0.2%) |
| Mar 2021 | - | -$180.37M(+3.3%) | -$700.70M(-752.0%) |
| Dec 2020 | $107.47M(-123.5%) | -$174.53M(-26.7%) | $107.47M(-9.1%) |
| Sep 2020 | - | -$238.19M(+121.4%) | $118.21M(-59.1%) |
| Jun 2020 | - | -$107.60M(-117.1%) | $288.96M(-9.0%) |
| Mar 2020 | - | $627.79M(-483.3%) | $317.56M(-169.6%) |
| Dec 2019 | -$456.46M(+17.4%) | -$163.79M(+142.9%) | -$456.46M(+10.0%) |
| Sep 2019 | - | -$67.43M(-14.6%) | -$415.09M(-10.0%) |
| Jun 2019 | - | -$79.00M(-46.0%) | -$460.98M(-7.7%) |
| Mar 2019 | - | -$146.23M(+19.5%) | -$499.23M(+28.4%) |
| Dec 2018 | -$388.66M(+67.5%) | -$122.42M(+8.0%) | -$388.66M(+30.7%) |
| Sep 2018 | - | -$113.32M(-3.4%) | -$297.30M(+22.9%) |
| Jun 2018 | - | -$117.25M(+228.7%) | -$241.88M(+15.3%) |
| Mar 2018 | - | -$35.67M(+14.8%) | -$209.78M(-9.6%) |
| Dec 2017 | -$232.00M(-5.6%) | -$31.06M(-46.4%) | -$232.00M(-17.8%) |
| Sep 2017 | - | -$57.90M(-32.0%) | -$282.17M(-1.0%) |
| Jun 2017 | - | -$85.15M(+47.1%) | -$284.88M(+17.2%) |
| Mar 2017 | - | -$57.89M(-28.7%) | -$243.02M(-1.1%) |
| Dec 2016 | -$245.82M(+64.5%) | -$81.23M(+34.0%) | -$245.82M(+25.5%) |
| Sep 2016 | - | -$60.62M(+40.0%) | -$195.86M(+7.9%) |
| Jun 2016 | - | -$43.28M(-28.7%) | -$181.56M(+8.8%) |
| Mar 2016 | - | -$60.69M(+94.1%) | -$166.81M(+11.6%) |
| Dec 2015 | -$149.47M(+16.3%) | -$31.27M(-32.5%) | -$149.47M(+4.1%) |
| Sep 2015 | - | -$46.31M(+62.3%) | -$143.64M(+8.3%) |
| Jun 2015 | - | -$28.53M(-34.2%) | -$132.65M(-7.6%) |
| Mar 2015 | - | -$43.35M(+70.3%) | -$143.62M(+11.7%) |
| Dec 2014 | -$128.54M(+98.7%) | -$25.45M(-27.9%) | -$128.54M(+6.3%) |
| Sep 2014 | - | -$35.32M(-10.6%) | -$120.91M(+14.6%) |
| Jun 2014 | - | -$39.50M(+39.8%) | -$105.47M(+35.3%) |
| Mar 2014 | - | -$28.27M(+58.6%) | -$77.97M(+20.5%) |
| Dec 2013 | -$64.69M(+117.9%) | -$17.82M(-10.3%) | -$64.69M(+19.7%) |
| Sep 2013 | - | -$19.88M(+65.6%) | -$54.03M(+28.8%) |
| Jun 2013 | - | -$12.00M(-19.9%) | -$41.96M(+17.7%) |
| Mar 2013 | - | -$14.99M(+109.5%) | -$35.64M(+20.0%) |
| Dec 2012 | -$29.69M(+25.4%) | -$7.16M(-8.3%) | -$29.69M(+5.4%) |
| Sep 2012 | - | -$7.80M(+37.4%) | -$28.18M(+1.0%) |
| Jun 2012 | - | -$5.68M(-37.2%) | -$27.90M(+23.1%) |
| Mar 2012 | - | -$9.05M(+60.2%) | -$22.66M(-4.3%) |
| Dec 2011 | -$23.68M(+55.7%) | -$5.65M(-24.9%) | -$23.68M(+18.9%) |
| Sep 2011 | - | -$7.52M(+1602.0%) | -$19.92M(+31.3%) |
| Jun 2011 | - | -$442.00K(-95.6%) | -$15.17M(-20.0%) |
| Mar 2011 | - | -$10.07M(+433.2%) | -$18.96M(+24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$15.21M(+72.8%) | -$1.89M(-31.9%) | -$15.21M(+5.8%) |
| Sep 2010 | - | -$2.77M(-34.5%) | -$14.38M(+7.8%) |
| Jun 2010 | - | -$4.24M(-32.9%) | -$13.34M(-1.1%) |
| Mar 2010 | - | -$6.31M(+497.2%) | -$13.50M(+53.4%) |
| Dec 2009 | -$8.80M(-28.7%) | -$1.06M(-39.2%) | -$8.80M(-13.9%) |
| Sep 2009 | - | -$1.74M(-60.4%) | -$10.22M(-19.6%) |
| Jun 2009 | - | -$4.39M(+171.8%) | -$12.71M(+33.4%) |
| Mar 2009 | - | -$1.61M(-34.8%) | -$9.53M(-22.8%) |
| Dec 2008 | -$12.34M(-50.0%) | -$2.48M(-41.4%) | -$12.34M(-28.2%) |
| Sep 2008 | - | -$4.23M(+249.1%) | -$17.19M(-2.2%) |
| Jun 2008 | - | -$1.21M(-72.6%) | -$17.58M(-25.5%) |
| Mar 2008 | - | -$4.43M(-39.6%) | -$23.61M(-4.3%) |
| Dec 2007 | -$24.68M(+19.7%) | -$7.33M(+58.6%) | -$24.68M(+9.7%) |
| Sep 2007 | - | -$4.62M(-36.2%) | -$22.49M(-4.1%) |
| Jun 2007 | - | -$7.24M(+31.7%) | -$23.45M(+12.6%) |
| Mar 2007 | - | -$5.49M(+6.8%) | -$20.82M(+1.0%) |
| Dec 2006 | -$20.61M(+40.5%) | -$5.15M(-7.6%) | -$20.61M(+1.9%) |
| Sep 2006 | - | -$5.57M(+20.9%) | -$20.24M(+30.6%) |
| Jun 2006 | - | -$4.61M(-12.8%) | -$15.50M(-0.5%) |
| Mar 2006 | - | -$5.29M(+10.9%) | -$15.58M(+6.2%) |
| Dec 2005 | -$14.67M(-38.3%) | -$4.77M(+475.4%) | -$14.67M(+10.0%) |
| Sep 2005 | - | -$828.90K(-82.3%) | -$13.33M(-26.5%) |
| Jun 2005 | - | -$4.69M(+7.1%) | -$18.15M(-11.2%) |
| Mar 2005 | - | -$4.38M(+27.6%) | -$20.43M(-14.1%) |
| Dec 2004 | -$23.78M(+36.0%) | -$3.43M(-39.2%) | -$23.78M(-4.8%) |
| Sep 2004 | - | -$5.65M(-19.0%) | -$24.98M(+9.6%) |
| Jun 2004 | - | -$6.97M(-9.8%) | -$22.79M(+20.8%) |
| Mar 2004 | - | -$7.73M(+67.0%) | -$18.86M(+7.9%) |
| Dec 2003 | -$17.48M(-13.7%) | -$4.63M(+33.8%) | -$17.48M(+6.1%) |
| Sep 2003 | - | -$3.46M(+13.6%) | -$16.47M(-2.8%) |
| Jun 2003 | - | -$3.04M(-52.0%) | -$16.94M(-23.5%) |
| Mar 2003 | - | -$6.35M(+75.4%) | -$22.14M(+9.3%) |
| Dec 2002 | -$20.26M(+58.0%) | -$3.62M(-7.8%) | -$20.26M(-0.2%) |
| Sep 2002 | - | -$3.93M(-52.3%) | -$20.31M(+5.3%) |
| Jun 2002 | - | -$8.24M(+84.2%) | -$19.28M(+32.9%) |
| Mar 2002 | - | -$4.47M(+22.1%) | -$14.51M(+13.1%) |
| Dec 2001 | -$12.82M(+40.5%) | -$3.66M(+26.1%) | -$12.82M(+2.8%) |
| Sep 2001 | - | -$2.91M(-16.1%) | -$12.48M(+10.7%) |
| Jun 2001 | - | -$3.46M(+24.1%) | -$11.27M(+7.3%) |
| Mar 2001 | - | -$2.79M(-15.9%) | -$10.50M(+15.0%) |
| Dec 2000 | -$9.13M(+20.1%) | -$3.32M(+95.2%) | -$9.13M(+18.4%) |
| Sep 2000 | - | -$1.70M(-36.9%) | -$7.71M(-2.5%) |
| Jun 2000 | - | -$2.69M(+90.1%) | -$7.91M(+6.7%) |
| Mar 2000 | - | -$1.42M(-25.4%) | -$7.42M(-2.4%) |
| Dec 1999 | -$7.60M(+13.4%) | -$1.90M(0.0%) | -$7.60M(-3.8%) |
| Sep 1999 | - | -$1.90M(-13.6%) | -$7.90M(+25.4%) |
| Jun 1999 | - | -$2.20M(+37.5%) | -$6.30M(-1.6%) |
| Mar 1999 | - | -$1.60M(-27.3%) | -$6.40M(-4.5%) |
| Dec 1998 | -$6.70M(+123.3%) | -$2.20M(+633.3%) | -$6.70M(+19.6%) |
| Sep 1998 | - | -$300.00K(-87.0%) | -$5.60M(-11.1%) |
| Jun 1998 | - | -$2.30M(+21.1%) | -$6.30M(+40.0%) |
| Mar 1998 | - | -$1.90M(+72.7%) | -$4.50M(+50.0%) |
| Dec 1997 | -$3.00M(+87.5%) | -$1.10M(+10.0%) | -$3.00M(+57.9%) |
| Sep 1997 | - | -$1.00M(+100.0%) | -$1.90M(+111.1%) |
| Jun 1997 | - | -$500.00K(+25.0%) | -$900.00K(+125.0%) |
| Mar 1997 | - | -$400.00K | -$400.00K |
| Dec 1996 | -$1.60M | - | - |
FAQ
- What is Sarepta Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual CFO year-on-year change?
- What is Sarepta Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly CFO year-on-year change?
- What is Sarepta Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM CFO year-on-year change?
What is Sarepta Therapeutics annual cash flow from operations?
The current annual CFO of SRPT is -$205.79M
What is the all time high annual CFO for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual cash flow from operations is $107.47M
What is Sarepta Therapeutics annual CFO year-on-year change?
Over the past year, SRPT annual cash flow from operations has changed by +$295.21M (+58.92%)
What is Sarepta Therapeutics quarterly cash flow from operations?
The current quarterly CFO of SRPT is -$583.44M
What is the all time high quarterly CFO for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly cash flow from operations is $627.79M
What is Sarepta Therapeutics quarterly CFO year-on-year change?
Over the past year, SRPT quarterly cash flow from operations has changed by -$341.36M (-141.01%)
What is Sarepta Therapeutics TTM cash flow from operations?
The current TTM CFO of SRPT is -$547.15M
What is the all time high TTM CFO for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM cash flow from operations is $317.56M
What is Sarepta Therapeutics TTM CFO year-on-year change?
Over the past year, SRPT TTM cash flow from operations has changed by -$13.47M (-2.52%)